![Brenda D. Gavin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brenda D. Gavin
Direktor/Vorstandsmitglied bei
Eximias Pharmaceutical Corp.
Profil
Brenda D.
Gavin is the founder of GSK Equity Investments Ltd. (1989) and Quaker Partners Management LP (2002).
She is currently a Director at Eximias Pharmaceutical Corp., Advisor at The Pennsylvania State University, and Director and Founder at Penn State Research Foundation.
Dr. Gavin's education history includes a doctorate from the University of Missouri (1977), an undergraduate degree from Baylor University (1970), and an MBA from The University of Texas at Austin (1981).
Aktive Positionen von Brenda D. Gavin
| Unternehmen | Position | Beginn |
|---|---|---|
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer disorders | Direktor/Vorstandsmitglied | - |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Penn State Research Foundation
 Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides scientific research services for improving human conditions | Direktor/Vorstandsmitglied | 01.01.2003 |
Ehemalige bekannte Positionen von Brenda D. Gavin
| Unternehmen | Position | Ende |
|---|---|---|
Quaker Partners Management LP
 Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Gründer | 01.03.2016 |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Direktor/Vorstandsmitglied | 29.01.2014 |
| CELATOR PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | - |
| OCERA THERAPEUTICS INC | Direktor/Vorstandsmitglied | 19.09.2011 |
| TENGION, INC. | Direktor/Vorstandsmitglied | 10.08.2011 |
Ausbildung von Brenda D. Gavin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
29
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 29 |
|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Synbiotics LLC
 Synbiotics LLC Medical SpecialtiesHealth Technology Develops monoclonal antibody-based diagnostic and biological products | Health Technology |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | Health Technology |
Eximias Pharmaceutical Corp.
Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer disorders | Health Technology |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
TetraLogic Pharmaceuticals Corp.
 TetraLogic Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on discovering and developing novel small molecule therapeutics in oncology and infectious diseases | Health Technology |
Diasome Pharmaceuticals, Inc.
 Diasome Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage diabetes therapeutics company which designs and develops insulin-based therapies for the treatment of diabetes | Health Technology |
GSK Equity Investments Ltd.
 GSK Equity Investments Ltd. Investment ManagersFinance GSK Equity invests in companies located in the United States and United kingdom. The firm targets companies operating in the field of biotechnology sector. It provides financing for early stage capital requirements. | Finance |
University of Missouri
 University of Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SmithKline Beecham Plc /Animal Health Unit/
 SmithKline Beecham Plc /Animal Health Unit/ Pharmaceuticals: MajorHealth Technology Animal vaccines, antibiotics, etc. | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Quaker Partners Management LP
Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management invests in healthcare companies located in the United States primarily in East Coast. The firm targets companies operating in the fields of biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals and healthcare services. It participates in seed and early stage capital requirements. | Finance |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance BioAdvance invests in companies located in the United States, primarily in New York and Washington, D.C. The firm targets companies operating in the fields of medical devices, digital health, diagnostics and research tools in healthcare sector. It provides financing for seed and early stage capital requirements with an investment size of USD 0.5 - 5 million and also acts as lead investor. | Finance |
Baylor University
 Baylor University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celator Pharmaceuticals Corp.
 Celator Pharmaceuticals Corp. BiotechnologyHealth Technology Develops antibody-based therapies to treat cancer | Health Technology |
Evoke MicroMass
 Evoke MicroMass Specialty TelecommunicationsCommunications Provides healthcare communication programs | Communications |
GlaxoSmithKline Research & Development
 GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
EuclidSR Partners
 EuclidSR Partners Investment ManagersFinance EuclidSR Partners seeks investment opportunities located in the US. The firm target companies operating in the fields of information technology, Convergence, Life sciences. The firm provides financing for early stage capital requirements. | Finance |
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Tech Partners invests in companies located in the US. The firm focuses on IT, life sciences and physical sciences. It participates in seed and early-stage capital requirements. | Finance |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services Provides business association services | Commercial Services |
Innovation Philadelphia, Inc.
 Innovation Philadelphia, Inc. Investment ManagersFinance Innovation Philadelphia invests in companies located in the United States, primarily in the Greater Philadelphia region. The firm targets companies operating in the fields of technology & life sciences, biotechnology, pharmaceuticals and medical-devices sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Finance |
Greater Philadelphia Venture Group | |
BioLeap, Inc.
 BioLeap, Inc. Pharmaceuticals: MajorHealth Technology Discovers, designs and develops drug pharmaceutical products | Health Technology |
Penn State Research Foundation
Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Provides scientific research services for improving human conditions | Commercial Services |
